Second malignancy after treatment of acute promyelocytic leukemia: experience of GIMEMA trials. Gruppo Italiano Malattie Ematologiche dell'Adulto

Blood. 2002 Aug 15;100(4):1514-5. doi: 10.1182/blood-2002-03-0886.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Humans
  • Leukemia, Myeloid, Acute / chemically induced
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Myelodysplastic Syndromes / chemically induced
  • Neoplasms / chemically induced*

Substances

  • Antineoplastic Agents